Stock Events

Stock Events

Search...

TheraVet SA

€0.25

1

-€0.01-1.98% Friday 15:18

Statistics

Day High

0.25

Day Low

0.24

52W High

2.4

52W Low

0.24

Volume

20,662

Avg. Volume

6,052

Mkt Cap

21.6M

P/E Ratio

-

Dividend Yield

-

Dividend

-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ALVET.PA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Zoetis Inc. is a global leader in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines, similar to TheraVet's focus on veterinary products.

Elanco Animal Health

Elanco Animal Health Incorporated operates in the same industry, providing comprehensive products and knowledge services to improve animal health.

Phibro Animal Health

Phibro Animal Health Corporation produces animal health and mineral nutrition products, competing in the same sector as TheraVet.

PetIQ, Inc. provides veterinary wellness products and services, directly competing with TheraVet's market in veterinary care.

Idexx Laboratories

IDEXX Laboratories, Inc. offers diagnostic and healthcare products for animals, competing in the broader animal health sector alongside TheraVet.

Patterson Companies

Patterson Companies, Inc. distributes veterinary supplies, competing with TheraVet in the supply chain aspect of animal health products.

Abeona Therapeutics

Abeona Therapeutics Inc. focuses on developing gene and cell therapies, which could overlap with TheraVet's therapeutic approaches in veterinary medicine.

Verona Pharma plc works on respiratory diseases treatment, which could compete indirectly by offering alternative treatments in specific veterinary applications.

About

TheraVet SA, a veterinary biotechnology company, provides osteoarticular treatments for animals in Belgium, France, Switzerland, the United Kingdom, and the United States. The company primarily provides products for osteoarthritis, ligament and tendon injuries, and bone surgery in cats, dogs, and horses. It offers BIOCERA-VET for osseointegration and bone remodelling; and VISCO-VET, an injectable visco-regenerative gel based on hyaluronic acid with anti-inflammatory properties that promotes the effect of active components, as well as acts as a cell colonization supporting tissue regeneration. The company was incorporated in 2017 and is headquartered in Jumet, Belgium.

Show more...

CEO

Employees

6

Country

BE

ISIN

BE0974387194

WKN

000A3CSTJ

Listings